Filing Details
- Accession Number:
- 0001209191-21-032978
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-14 20:12:11
- Reporting Period:
- 2021-05-12
- Accepted Time:
- 2021-05-14 20:12:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204660 | P Charles Slacik | 9975 Summers Ridge Road San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-12 | 1,040 | $0.00 | 12,255 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-05-12 | 191 | $0.00 | 12,446 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-05-12 | 19 | $0.00 | 12,465 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-05-13 | 1,000 | $113.26 | 11,465 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-05-14 | 612 | $0.00 | 12,077 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-05-14 | 122 | $0.00 | 12,199 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2021-05-12 | 1,040 | $0.00 | 1,040 | $0.00 |
| Common Stock | Restricted Stock Units (Converted) | Disposition | 2021-05-12 | 191 | $0.00 | 191 | $0.00 |
| Common Stock | Restricted Stock Units (Premium) | Disposition | 2021-05-12 | 19 | $0.00 | 19 | $0.00 |
| Common Stock | Restricted Stock Units (Converted) | Disposition | 2021-05-14 | 612 | $0.00 | 612 | $0.00 |
| Common Stock | Restricted Stock Units (Premium) | Disposition | 2021-05-14 | 122 | $0.00 | 122 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-05-12 | 2021-05-12 | No | 4 | M | Direct |
| 0 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct |
Footnotes
- Reflects release of restricted stock units that were previously reported on Form 4.
- The weighted average sale price for these transactions was $113.258 per share, with a range of $112.62 to $120.00. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- Restricted stock units convert into common stock on a one-for-one basis.
- Shares vested and released on the transaction date pursuant to Issuer's deferred compensation plan.
Billionaire Hedge Funds
